Furthermore, the fact that heterozygous global deletion of IRF5 markedly reduces disease in lupus models suggested that loss of 1 allele of IRF5 in B cells might confer protection (5, 10, 28, 29). This evidence concerns the gene IRF5 and systemic lupus erythematosus.